Heninger, Erika
Kosoff, David
Rodems, Tamara S.
Sethakorn, Nan
Singh, Anupama
Gungurthi, Harshitha
Carlson, Kristin N.
Yang, Bing
Gilsdorf, Cole
Pasch, Cheri A.
Deming, Dustin A.
Ellis, Leigh
Beebe, David J.
Jarrard, David F.
Lang, Joshua M. http://orcid.org/0000-0002-0943-8872
Funding for this research was provided by:
Foundation for the National Institutes of Health (P30 CA014520)
Prostate Cancer Foundation (19CHAL12)
Office of the Under Secretary of Defense (W81XWH-16-1-0511)
U.S. Department of Veterinary Affairs Advanced Fellowship in Women's Health (T32 HL07899)
Article History
Received: 16 August 2021
Accepted: 12 September 2021
First Online: 28 September 2021
Declarations
:
: JML and DJB hold equity in Salus Discovery, DJB holds equity in Bellbrook Labs, Tasso, Stacks to the Future, Lynx Biosciences, Onexio Biosystems and Flambeau Diagnostics. Salus Discovery and Stacks to the Future have licensed some of the technology described in the manuscript. However, none of these companies supported this work. All issues regarding conflict of interest are managed by the University of Wisconsin and a COI management plan is in place.